Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12(1):31–46.

Article  PubMed  CAS  Google Scholar 

Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–63.

Article  PubMed  Google Scholar 

Weinberg RA. Oncogenes and tumor suppressor genes. CA Cancer J Clin. 1994;44(3):160–70.

Article  PubMed  CAS  Google Scholar 

Kiri S, Ryba T. Cancer, metastasis, and the epigenome. Mol Cancer. 2024;23(1):154.

Article  PubMed  PubMed Central  Google Scholar 

Weinberg RA. Tumor suppressor genes. Science. 1991;254(5035):1138–46.

Article  PubMed  CAS  Google Scholar 

Chen L, Liu S, Tao Y. Regulating tumor suppressor genes: post-translational modifications. Signal Transduct Target Ther. 2020;5(1):90.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Weinstein IB, Joe A. Oncogene addiction. Cancer Res. 2008;68(9):3077–80; discussion 3080.

Article  PubMed  CAS  Google Scholar 

Dhanasekaran R, et al. The MYC oncogene - the grand orchestrator of cancer growth and immune evasion. Nat Rev Clin Oncol. 2022;19(1):23–36.

Article  PubMed  CAS  Google Scholar 

Otano I, et al. At the crossroads of immunotherapy for oncogene-addicted subsets of NSCLC. Nat Rev Clin Oncol. 2023;20(3):143–59.

Article  PubMed  Google Scholar 

Prior IA, Hood FE, Hartley JL. The frequency of ras mutations in cancer. Cancer Res. 2020;80(14):2969–74.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Huang L, et al. KRAS mutation: from undruggable to druggable in cancer. Signal Transduct Target Ther. 2021;6(1):386.

Article  PubMed  PubMed Central  Google Scholar 

Hofmann MH, et al. Expanding the reach of precision oncology by drugging all KRAS mutants. Cancer Discov. 2022;12(4):924–37.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74.

Article  PubMed  CAS  Google Scholar 

Pavlova NN, Zhu J, Thompson CB. The hallmarks of cancer metabolism: Still emerging. Cell Metab. 2022;34(3):355–77.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Li M, et al. Metabolism, metabolites, and macrophages in cancer. J Hematol Oncol. 2023;16(1):80.

Article  PubMed  PubMed Central  Google Scholar 

Martinez-Reyes I, Chandel NS. Cancer metabolism: looking forward. Nat Rev Cancer. 2021;21(10):669–80.

Article  PubMed  CAS  Google Scholar 

Lin J, et al. Metabolic reprogramming in the tumor microenvironment of liver cancer. J Hematol Oncol. 2024;17(1):6.

Article  PubMed  PubMed Central  Google Scholar 

Liberti MV, Locasale JW. The warburg effect: how does it benefit cancer cells? Trends Biochem Sci. 2016;41(3):211–8.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Fendt SM. 100 years of the Warburg effect: a cancer metabolism endeavor. Cell. 2024;187(15):3824–8.

Article  PubMed  CAS  Google Scholar 

Boese AC, Kang S. Mitochondrial metabolism-mediated redox regulation in cancer progression. Redox Biol. 2021;42:101870.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Giacomello M, et al. The cell biology of mitochondrial membrane dynamics. Nat Rev Mol Cell Biol. 2020;21(4):204–24.

Article  PubMed  CAS  Google Scholar 

Bian X, et al. Lipid metabolism and cancer. J Exp Med. 2021;218(1):e20201606.

Article  PubMed  CAS  Google Scholar 

Yu W, et al. Contradictory roles of lipid metabolism in immune response within the tumor microenvironment. J Hematol Oncol. 2021;14(1):187.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Altman BJ, Stine ZE, Dang CV. From Krebs to clinic: glutamine metabolism to cancer therapy. Nat Rev Cancer. 2016;16(10):619–34.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Shen Y, et al. Glutamine metabolism: from proliferating cells to cardiomyocytes. Metabolism. 2021;121:154778.

Article  PubMed  CAS  Google Scholar 

Vettore L, Westbrook RL, Tennant DA. New aspects of amino acid metabolism in cancer. Br J Cancer. 2020;122(2):150–6.

Article  PubMed  CAS  Google Scholar 

Butler M, van der Meer LT, van Leeuwen FN. Amino acid depletion therapies: starving cancer cells to death. Trends Endocrinol Metab. 2021;32(6):367–81.

Article  PubMed  CAS  Google Scholar 

Singhal A, Li BT, O’Reilly EM. Targeting KRAS in cancer. Nat Med. 2024;30(4):969–83.

Article  PubMed  CAS  Google Scholar 

Drosten M, Barbacid M. Targeting the MAPK Pathway in KRAS-Driven Tumors. Cancer Cell. 2020;37(4):543–50.

Article  PubMed  CAS  Google Scholar 

Murugan AK, Grieco M, Tsuchida N. RAS mutations in human cancers: Roles in precision medicine. Semin Cancer Biol. 2019;59:23–35.

Article  PubMed  CAS  Google Scholar 

Canon J, et al. The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity. Nature. 2019;575(7781):217–23.

Article  PubMed  CAS  Google Scholar 

Hallin J, et al. The KRAS(G12C) inhibitor MRTX849 provides insight toward therapeutic susceptibility of kras-mutant cancers in mouse models and patients. Cancer Discov. 2020;10(1):54–71.

Article  PubMed  CAS